Screener/Healthcare/Biotechnology

CHRS

Coherus Oncology, Inc.NASDAQ
$1.75+0.04 (+2.05%)
$0.71
$2.62
$1.69
$1.76
EPS (TTM)$1.37
P/E Ratio1.26
Dividend Yield
Market Cap$232.6M
Volume103K
Prev Close$1.71
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$11.6M-$35.5M$-0.3167.8%-307.1%
Q2 '25$10.3M$297.8M$2.5766.9%2903.9%
Q1 '25$7.6M-$56.6M$-0.4965.1%-744.4%
Q4 '24$54.1M-$50.7M$-0.4037.5%-93.6%
Q3 '24$70.8M-$10.8M$-0.0970.7%-15.2%
Q2 '24$65.0M-$12.9M$-0.1156.3%-19.9%
Q1 '24$77.1M$102.9M$0.8355.1%133.5%
Q4 '23$91.5M-$79.7M$-0.747.6%-87.0%
Get Your Daily Market Recap